Journal of the American Academy of Child & Adolescent Psychiatry
ARTICLESPsychotropic and Anticonvulsant Drugs in Subjects with Autism: Prevalence and Patterns of Use
REFERENCES (32)
- et al.
Methylphenidate treatment of hyperactive autistic children
J Am Acad Child Adolesc Psychiatry
(1988) - et al.
Fluoxetine treatment of children and adults with autistic disorder and mental retardation
J Am Acad Child Adolesc Psychiatry
(1992) - et al.
Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities
J Am Acad Child Adolesc Psychiatry
(1992) - et al.
Clomipramine in autism: preliminary evidence of efficacy
J Am Acad Child Adolesc Psychiatry
(1992) - et al.
Randomized trial of methylphenidate for an autistic child
J Am Acad Child Adolesc Psychiatry
(1988) Stimulant drug effects in developmental disorders and hyperactivity: toward a resolution of disparate findings
J Autism Dev Disord
(1982)- et al.
Psychoactive drugs in group homes: prevalence and relation to demographic/psychiatric variables
Am J Ment Retard
(1995) - et al.
Patterns of drug use, methodological considerations, measurement techniques, and future trends
- et al.
Vitamin, mineral, and dietary treatments
- et al.
Beta blockers in mental retardation and developmental disorders
J Child Adolesc Psychopharmacol
(1991)
The Practice of Social Research
Pharmacotherapy in autism: an overview
Psychopharmacological treatment
Response to triiodothyronine and dextroamphetamine: a study of preschool schizophrenic children
J Autism Child Schizophr
Levodopa and levoamphetamine: a crossover study in young schizophrenic children
Curr Ther Res
Antiepileptics (anticonvulsants)
Cited by (113)
ADHD severity as a predictor of cognitive task performance in children with Autism Spectrum Disorder (ASD)
2021, Research in Developmental DisabilitiesProblem behaviours and Major Depressive Disorder in adults with intellectual disability and autism
2018, Psychiatry ResearchEffectiveness of yoga training program on the severity of autism
2017, Complementary Therapies in Clinical PracticeCitation Excerpt :The ASD prevalence has been increasing since the last two decades, while the number of evidence-based clinical interventions that address both core co-morbid and ASD symptoms are limited in number and availability and overwhelmed by demand [5]. Various interventions such as pharmacological intervention, parental and caregivers training education are suggested to develop attention, social skills, language/communication and physical behavior in ASD persons [6–9] in addition, educational/behavioral therapies [10–12], complementary and alternative medicine (CAM therapies) [10,11], elimination diets, mega doses of selected vitamins [10,13,14] and early intensive behavioral intervention (EIBI) [15–17] are suggested. Today, only 28% of patients with ASD receive treatment using complementary and alternative medicine (CAM), a rate twice that of the non-ASD people [18,19].
Pharmacological treatments use among children, adolescents and young adults with autism spectrum disorder in France: An overview based on parental experience
2017, Neuropsychiatrie de l'Enfance et de l'AdolescenceADHD severity as it relates to comorbid psychiatric symptomatology in children with Autism Spectrum Disorders (ASD)
2017, Research in Developmental DisabilitiesCitation Excerpt :Nineteen children (19%) were taking two medications, and six children (6%) were receiving three or more. Although we recognized that children taking psychotropic medications were likely to have greater comorbid psychiatric symptoms, if we had excluded them, we would have created a sample that was not representative of children with ASD (Aman, Van Bourgondien, Wolford, & Sarphare, 1995). The SB5 was used as the measure of intellectual level.
Epilepsy Associated with ASD and Intellectual Disability
2016, Neuronal and Synaptic Dysfunction in Autism Spectrum Disorder and Intellectual Disability
This work was supported in part by NIMH research grant MH 44122 to Dr. Aman. The authors thank Sharon Van Fossen and Anthony Allen for practical assistance in this study and Mr. Alistair Stewart (Auckland University) and Dr. John Spicer (Massey University) for guidance on the logistic regression analyses.